Rubén
Pío Osés
Catedrático de Universidad


Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (7)
2023
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
2021
-
Molecular biomarkers in early stage lung cancer
Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185
-
Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography
Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106
2019
-
5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging
Thorax, Vol. 74, Núm. 4, pp. 371-379
-
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
2016
-
A novel epigenetic signature for early diagnosis in lung cancer
Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371